Recent advances in the molecular mechanism of sex disparity in hepatocellular carcinoma (Review)
- Authors:
- Yanmeng Li
- Anjian Xu
- Siyu Jia
- Jian Huang
-
Affiliations: Experimental Center, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China - Published online on: March 8, 2019 https://doi.org/10.3892/ol.2019.10127
- Pages: 4222-4228
This article is mentioned in:
Abstract
 |
 |
 |
|
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF and Zein NN: The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 51:1972–1978. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
El-Serag HB: Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 142:1264–1273.e1. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Torre LA, Siegel RL, Ward EM and Jemal A: Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM and Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 317:121–124. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS and Chen PJ: Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B. Hepatology. 50:1392–1402. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Liu C, Ren YF, Dong J, Ke MY, Ma F, Monga SPS, Wu R, Lv Y and Zhang XF: Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma. Cancer Lett. 410:20–31. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang HL, Xu D, Yu H, Ma X, Lin GF, Ma DY and Jin JZ: DAX-1 inhibits hepatocellular carcinoma proliferation by inhibiting β-catenin transcriptional activity. Cell Physiol Biochem. 34:734–742. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chua HH, Tsuei DJ, Lee PH, Jeng YM, Lu J, Wu JF, Su DS, Chen YH, Chien CS, Kao PC, et al: RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma. Hepatology. 62:1480–1496. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bertani S, Pineau P, Loli S, Moura J, Zimic M, Deharo E and Ruiz E: An atypical age-specific pattern of hepatocellular carcinoma in Peru: A threat for Andean populations. PLoS One. 8:e677562013. View Article : Google Scholar : PubMed/NCBI | |
|
Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, et al: Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 15:1791–1799. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC and Chen CJ: Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk. Hepatology. 38:1393–1400. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Bigsby RM and Caperell-Grant A: The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesis. Carcinogenesis. 32:1162–1166. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Prieto J: Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol. 48:380–381. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YC, Xu GL, Jia WD, Han SJ, Ren WH, Wang W, Liu WB, Zhang CH and Chen H: Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression. Inflammation. 35:143–149. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Karin M: Nuclear factor-kappaB in cancer development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Shi L, Feng Y, Lin H, Ma R and Cai X: Role of estrogen in hepatocellular carcinoma: Is inflammation the key? J Transl Med. 12:932014. View Article : Google Scholar : PubMed/NCBI | |
|
Ren J, Chen GG, Liu Y, Su X, Hu B, Leung BC, Wang Y, Ho RL, Yang S, Lu G, et al: Cytochrome P450 1A2 metabolizes 17β-estradiol to suppress hepatocellular carcinoma. PLoS One. 11:e01538632016. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng B, Zhu YJ, Wang HY and Chen L: Gender disparity in hepatocellular carcinoma (HCC): Multiple underlying mechanisms. Sci China Life Sci. 60:575–584. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Teng Y, Litchfield LM, Ivanova MM, Prough RA, Clark BJ and Klinge CM: Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor. Mol Cell Endocrinol. 392:23–36. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Shen M, Cao J and Shi H: Effects of estrogen and estrogen receptors on transcriptomes of HepG2 Cells: A preliminary study using RNA sequencing. Int J Endocrinol. 2018:57891272018. View Article : Google Scholar : PubMed/NCBI | |
|
Shen M and Shi H: Estradiol and estrogen receptor agonists oppose oncogenic actions of leptin in HepG2 cells. PLoS One. 11:e01514552016. View Article : Google Scholar : PubMed/NCBI | |
|
Pearce ST and Jordan VC: The biological role of estrogen receptors alpha and beta in cancer. Crit Rev Oncol Hematol. 50:3–22. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Iyer JK, Kalra M, Kaul A, Payton ME and Kaul R: Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis. World J Gastroenterol. 23:6802–6816. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Xu H, Wei Y, Zhang Y, Xu Y, Li F, Liu J, Zhang W, Han X, Tan R and Shen P: Oestrogen attenuates tumour progression in hepatocellular carcinoma. J Pathol. 228:216–229. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wei Q, Guo P, Mu K, Zhang Y, Zhao W, Huai W, Qiu Y, Li T, Ma X, Liu Y, et al: Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome. Lab Invest. 95:804–816. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hou J, Xu J, Jiang R, Wang Y, Chen C, Deng L, Huang X, Wang X and Sun B: Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. Hepatology. 57:678–688. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yang W, Lu Y, Xu Y, Xu L, Zheng W, Wu Y, Li L and Shen P: Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs). J Biol Chem. 287:40140–40149. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Deng L, Yang H, Tang J, Lin Z, Yin A, Gao Y, Wang X, Jiang R and Sun B: Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis. J Exp Clin Cancer Res. 34:1282015. View Article : Google Scholar : PubMed/NCBI | |
|
Lin YM, Velmurugan BK, Yeh YL, Tu CC, Ho TJ, Lai TY, Tsai CH, Tsai FJ, Tsai CH and Huang CY: Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma. Oncol Rep. 30:3027–3031. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bartel DP and Chen CZ: Micromanagers of gene expression: The potentially widespread influence of metazoan microRNAs. Nat Rev Genet. 5:396–400. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Amodio G, Sasso E, D'Ambrosio C, Scaloni A, Moltedo O, Franceschelli S, Zambrano N and Remondelli P: Identification of a microRNA (miR-663a) induced by ER stress and its target gene PLOD3 by a combined microRNome and proteome approach. Cell Biol Toxicol. 32:285–303. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sun L, Guo Z, Sun J, Li J, Dong Z, Zhang Y, Chen J, Kan Q and Yu Z: MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathway. Biomed Pharmacother. 107:168–176. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J: MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Chen PJ, Yeh SH, Liu WH, Lin CC, Huang HC, Chen CL, Chen DS and Chen PJ: Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis. Hepatology. 56:632–643. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sun J, Lu H, Wang X and Jin H: MicroRNAs in hepatocellular carcinoma: Regulation, function, and clinical implications. ScientificWorldJournal. 2013:9242062013. View Article : Google Scholar : PubMed/NCBI | |
|
Marchesi F, Regazzo G, Palombi F, Terrenato I, Sacconi A, Spagnuolo M, Donzelli S, Marino M, Ercolani C, Di Benedetto A, et al: Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: An explorative pilot study. J Exp Clin Cancer Res. 37:952018. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang R, Deng L, Zhao L, Li X, Zhang F, Xia Y, Gao Y, Wang X and Sun B: miR-22 promotes HBV-related hepatocellular carcinoma development in males. Clin Cancer Res. 17:5593–5603. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS and Chen PJ: MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology. 136:683–693. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Li CL, Yeh KH, Liu WH, Chen CL, Chen DS, Chen PJ and Yeh SH: Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma. Int J Cancer. 136:761–770. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Luu-The V: Assessment of steroidogenesis and steroidogenic enzyme functions. J Steroid Biochem Mol Biol. 137:176–182. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Niu ZS, Niu XJ and Wang WH: Genetic alterations in hepatocellular carcinoma: An update. World J Gastroenterol. 22:9069–9095. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Aleksic K, Lackner C, Geigl JB, Schwarz M, Auer M, Ulz P, Fischer M, Trajanoski Z, Otte M and Speicher MR: Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice. Hepatology. 53:895–904. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Na TY, Ka NL, Rhee H, Kyeong D, Kim MH, Seong JK, Park YN and Lee MO: Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma. Oncogene. 35:5435–5445. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Z, Chen GY, Long J, Li H and Huang J: Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma. Oncol Lett. 9:2839–2846. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tummala KS, Gomes AL, Yilmaz M, Graña O, Bakiri L, Ruppen I, Ximénez-Embún P, Sheshappanavar V, Rodriguez-Justo M, Pisano DG, et al: Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. Cancer Cell. 26:826–839. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Mazzotta A, Partipilo G, De Summa S, Giotta F, Simone G and Mangia A: Nuclear PARP1 expression and its prognostic significance in breast cancer patients. Tumour Biol. 37:6143–6153. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Markaverich BM, Shoulars K and Rodriguez MA: Luteolin regulation of estrogen signaling and cell cycle pathway genes in MCF-7 human breast cancer cells. Int J Biomed Sci. 7:101–111. 2011.PubMed/NCBI | |
|
Dantzer F, Schreiber V, Niedergang C, Trucco C, Flatter E, De La Rubia G, Oliver J, Rolli V, Ménissier-de Murcia J and de Murcia G: Involvement of poly(ADP-ribose) polymerase in base excision repair. Biochimie. 81:69–75. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Song D, Huang H, Wang J, Zhao Y, Hu X, He F, Yu L and Wu J: NF90 regulates PARP1 mRNA stability in hepatocellular carcinoma. Biochem Biophys Res Commun. 488:211–217. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ko HL and Ren EC: Novel poly (ADP-ribose) polymerase 1 binding motif in hepatitis B virus core promoter impairs DNA damage repair. Hepatology. 54:1190–1198. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Mukherjee RM, Shravanti GV, Jakkampudi A, Kota R, Jangala AL, Reddy PB, Rao PN, Gupta R and Reddy DN: Reduced expression of DNA damage repair genes high mobility group box1 and Poly(ADP-ribose) polymerase1 in inactive carriers of hepatitis B virus infection-A possible stage of viral integration. J Clin Exp Hepatol. 3:89–95. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Qadri I, Fatima K and AbdeL-Hafiz H: Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH. BMC Microbiol. 11:482011. View Article : Google Scholar : PubMed/NCBI | |
|
Hashimoto S and Egly JM: Trichothiodystrophy view from the molecular basis of DNA repair/transcription factor TFIIH. Hum Mol Genet. 18:R224–R230. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Schärer OD: Hot topics in DNA repair: The molecular basis for different disease states caused by mutations in TFIIH and XPG. DNA Repair (Amst). 7:339–344. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lee TH, Elledge SJ and Butel JS: Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol. 69:1107–1114. 1995.PubMed/NCBI | |
|
Djouder N: Boosting NAD(+) for the prevention and treatment of liver cancer. Mol Cell Oncol. 2:e10011992015. View Article : Google Scholar : PubMed/NCBI | |
|
Boniol M and Autier P: Prevalence of main cancer lifestyle risk factors in Europe in 2000. Eur J Cancer. 46:2534–2544. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Grohmann M, Wiede F, Dodd GT, Gurzov EN, Ooi GJ, Butt T, Rasmiena AA, Kaur S, Gulati T, Goh PK, et al: Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC. Cell. 175:1289–1306 e20. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H and Karin M: Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 140:197–208. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Xiong Y, Zhang J, Liu M, An M, Lei L and Guo W: Human leptin protein activates the growth of HepG2 cells by inhibiting PERK-mediated ER stress and apoptosis. Mol Med Rep. 10:1649–1655. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Vansaun MN, Mendonsa AM and Lee Gorden D: Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver disease. PLoS One. 8:e730542013. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Mo C, Huang S, Yang S, Lu Y, Peng Q, Wang J, Deng Y, Qin X and Liu Y: Over-expressed Testis-specific Protein Y-encoded 1 as a novel biomarker for male hepatocellular carcinoma. PLoS One. 9:e892192014. View Article : Google Scholar : PubMed/NCBI | |
|
Montella M, D'Arena G, Crispo A, Capunzo M, Nocerino F, Grimaldi M, Barbieri A, D'Ursi AM, Tecce MF, Amore A, et al: Role of sex hormones in the development and progression of hepatitis B virus-associated hepatocellular carcinoma. Int J Endocrinol. 2015:8545302015. View Article : Google Scholar : PubMed/NCBI | |
|
Beato M and Klug J: Steroid hormone receptors: An update. Hum Reprod Update. 6:225–236. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Chang CS, Kokontis J and Liao ST: Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science. 240:324–326. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S and Chang C: Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med. 2:32ra352010. View Article : Google Scholar : PubMed/NCBI | |
|
Barone M, Margiotta M, Scavo MP, Gentile A, Francioso D, Papagni S, Castellaneta A, Mallamaci R, Di Leo A and Francavilla A: Possible involvement of androgen receptor alterations in hepatocarcinogenesis. Dig Liver Dis. 41:665–670. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ma WL, Hsu CL, Wu MH, Wu CT, Wu CC, Lai JJ, Jou YS, Chen CW, Yeh S and Chang C: Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology. 135:947–955, 955.e1-5. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Yang WJ, Chang CJ, Yeh SH, Lin WH, Wang SH, Tsai TF, Chen DS and Chen PJ: Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways. Hepatology. 49:1515–1524. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, Zhao GJ, Ng SS, Lin MC, Yu J, et al: Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis. J Clin Invest. 121:3159–3175. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Koh WP, Yuan JM, Wang R, Govindarajan S, Oppenheimer R, Zhang ZQ, Yu MC and Ingles SA: Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma. Cancer. 117:3383–3392. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Castagnetta LA, Agostara B, Montalto G, Polito L, Campisi I, Saetta A, Itoh T, Yu B, Chen S and Carruba G: Local estrogen formation by nontumoral, cirrhotic, and malignant human liver tissues and cells. Cancer Res. 63:5041–5045. 2003.PubMed/NCBI | |
|
Zhang S, Shu R, Yue M and Zhang S: Effect of over-expression of zinc-finger protein (ZFX) on self-renewal and drug-resistance of hepatocellular carcinoma. Med Sci Monit. 22:3025–3034. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Park SJ, Jeong SY and Kim HJ: Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array. Cancer Genet Cytogenet. 166:56–64. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Wang ZM, Zhen SF, Wu XP, Ma DX, Li ZH, Liu B, Zhao ZL and Ke Y: Aberration of X chromosome in liver neoplasm detected by fluorescence in situ hybridization. Hepatobiliary Pancreat Dis Int. 3:110–114. 2004.PubMed/NCBI | |
|
Lalli E and Alonso J: Targeting DAX-1 in embryonic stem cells and cancer. Expert Opin Ther Targets. 14:169–177. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Zhang Z, Bi Y, Yang D, Zhang L and Liu J: Expression characteristics of β-catenin in scallop Chlamys farreri gonads and its role as a potential upstream gene of Dax1 through canonical Wnt signalling pathway regulating the spermatogenesis. PLoS One. 9:e1159172014. View Article : Google Scholar : PubMed/NCBI | |
|
Campbell DEK and Langlois VS: Expression of sf1 and dax-1 are regulated by thyroid hormones and androgens during Silurana tropicalis early development. Gen Comp Endocrinol. 259:34–44. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tsuei DJ, Lee PH, Peng HY, Lu HL, Su DS, Jeng YM, Hsu HC, Hsu SH, Wu JF, Ni YH and Chang MH: Male germ cell-specific RNA binding protein RBMY: A new oncogene explaining male predominance in liver cancer. PLoS One. 6:e269482011. View Article : Google Scholar : PubMed/NCBI | |
|
Yin YH, Li YY, Qiao H, Wang HC, Yang XA, Zhang HG, Pang XW, Zhang Y and Chen WF: TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma. Br J Cancer. 93:458–463. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Murakami S, Chishima S, Uemoto H, Sakamoto E, Sato T, Kurabe N, Kawasaki Y, Shibata T, Akiyama H and Tashiro F: The male-specific factor Sry harbors an oncogenic function. Oncogene. 33:2978–2986. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Murakami S, Ninomiya W, Sakamoto E, Shibata T, Akiyama H and Tashiro F: SRY and OCT4 are required for the acquisition of cancer stem cell-like properties and are potential differentiation therapy targets. Stem Cells. 33:2652–2663. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tsuei DJ, Hsu HC, Lee PH, Jeng YM, Pu YS, Chen CN, Lee YC, Chou WC, Chang CJ, Ni YH and Chang MH: RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts. Oncogene. 23:5815–5822. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Homayounfar K, Schwarz A, Enders C, Cameron S, Baumhoer D, Ramadori G, Lorf T, Gunawan B and Sander B: Etiologic influence on chromosomal aberrations in European hepatocellular carcinoma identified by CGH. Pathol Res Pract. 209:380–387. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hashimoto K, Mori N, Tamesa T, Okada T, Kawauchi S, Oga A, Furuya T, Tangoku A, Oka M and Sasaki K: Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH. Mod Pathol. 17:617–622. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Takeo S, Arai H, Kusano N, Harada T, Furuya T, Kawauchi S, Oga A, Hirano T, Yoshida T, Okita K and Sasaki K: Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: Comparison with comparative genomic hybridization analysis. Cancer Genet Cytogenet. 130:127–132. 2001. View Article : Google Scholar : PubMed/NCBI |
